1482 related articles for article (PubMed ID: 28822354)
1. 3D brain Organoids derived from pluripotent stem cells: promising experimental models for brain development and neurodegenerative disorders.
Lee CT; Bendriem RM; Wu WW; Shen RF
J Biomed Sci; 2017 Aug; 24(1):59. PubMed ID: 28822354
[TBL] [Abstract][Full Text] [Related]
2. Generation of iPSC-derived Human Brain Organoids to Model Early Neurodevelopmental Disorders.
Gabriel E; Gopalakrishnan J
J Vis Exp; 2017 Apr; (122):. PubMed ID: 28448044
[TBL] [Abstract][Full Text] [Related]
3. Central nervous system organoids for modeling neurodegenerative diseases.
Hou PS; Kuo HC
IUBMB Life; 2022 Aug; 74(8):812-825. PubMed ID: 35102668
[TBL] [Abstract][Full Text] [Related]
4. In vitro modeling for inherited neurological diseases using induced pluripotent stem cells: from 2D to organoid.
Nam KH; Yi SA; Jang HJ; Han JW; Lee J
Arch Pharm Res; 2020 Sep; 43(9):877-889. PubMed ID: 32761309
[TBL] [Abstract][Full Text] [Related]
5. Disease Modeling Using 3D Organoids Derived from Human Induced Pluripotent Stem Cells.
Ho BX; Pek NMQ; Soh BS
Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29561796
[TBL] [Abstract][Full Text] [Related]
6. From Neuronal Differentiation of iPSCs to 3D Neuro-Organoids: Modelling and Therapy of Neurodegenerative Diseases.
Bordoni M; Rey F; Fantini V; Pansarasa O; Di Giulio AM; Carelli S; Cereda C
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30544711
[TBL] [Abstract][Full Text] [Related]
7. Three-Dimensional Models for Studying Neurodegenerative and Neurodevelopmental Diseases.
Tsaridou S; Skamnelou M; Iliadou M; Lokka G; Parlapani E; Mougkogianni M; Danalatos RI; Kanellou A; Chlorogiannis DD; Kyrousi C; Taraviras S
Adv Exp Med Biol; 2020; 1195():35-41. PubMed ID: 32468456
[TBL] [Abstract][Full Text] [Related]
8. Opportunities and challenges for the use of induced pluripotent stem cells in modelling neurodegenerative disease.
Wu YY; Chiu FL; Yeh CS; Kuo HC
Open Biol; 2019 Jan; 9(1):180177. PubMed ID: 30958120
[TBL] [Abstract][Full Text] [Related]
9. Studying Human Neurological Disorders Using Induced Pluripotent Stem Cells: From 2D Monolayer to 3D Organoid and Blood Brain Barrier Models.
Logan S; Arzua T; Canfield SG; Seminary ER; Sison SL; Ebert AD; Bai X
Compr Physiol; 2019 Mar; 9(2):565-611. PubMed ID: 30873582
[TBL] [Abstract][Full Text] [Related]
10. The Emergence of Stem Cell-Based Brain Organoids: Trends and Challenges.
Gopalakrishnan J
Bioessays; 2019 Aug; 41(8):e1900011. PubMed ID: 31274205
[TBL] [Abstract][Full Text] [Related]
11. Development of brain organoid technology derived from iPSC for the neurodegenerative disease modelling: a glance through.
Jusop AS; Thanaskody K; Tye GJ; Dass SA; Wan Kamarul Zaman WS; Nordin F
Front Mol Neurosci; 2023; 16():1173433. PubMed ID: 37602192
[TBL] [Abstract][Full Text] [Related]
12. Modelling neurodegenerative diseases with 3D brain organoids.
Chang Y; Kim J; Park H; Choi H; Kim J
Biol Rev Camb Philos Soc; 2020 Oct; 95(5):1497-1509. PubMed ID: 32568450
[TBL] [Abstract][Full Text] [Related]
13. Studying Human Neurodevelopment and Diseases Using 3D Brain Organoids.
Tian A; Muffat J; Li Y
J Neurosci; 2020 Feb; 40(6):1186-1193. PubMed ID: 32024767
[No Abstract] [Full Text] [Related]
14. Brain Organoids: Expanding Our Understanding of Human Development and Disease.
Chuye LB; Dimitri A; Desai A; Handelmann C; Bae Y; Johari P; Jornet JM; Klejbor I; Stachowiak MK; Stachowiak EK
Results Probl Cell Differ; 2018; 66():183-206. PubMed ID: 30209660
[TBL] [Abstract][Full Text] [Related]
15. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
Liu Y; Deng W
Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
[TBL] [Abstract][Full Text] [Related]
16. Enhanced Neuronal Activity and Asynchronous Calcium Transients Revealed in a 3D Organoid Model of Alzheimer's Disease.
Yin J; VanDongen AM
ACS Biomater Sci Eng; 2021 Jan; 7(1):254-264. PubMed ID: 33347288
[TBL] [Abstract][Full Text] [Related]
17. In vitro models for ASD-patient-derived iPSCs and cerebral organoids.
Hohmann SS; Ilieva M; Michel TM
Prog Mol Biol Transl Sci; 2020; 173():355-375. PubMed ID: 32711817
[TBL] [Abstract][Full Text] [Related]
18. Modeling of Autism Using Organoid Technology.
Choi H; Song J; Park G; Kim J
Mol Neurobiol; 2017 Dec; 54(10):7789-7795. PubMed ID: 27844287
[TBL] [Abstract][Full Text] [Related]
19. Advancing Drug Discovery for Neurological Disorders Using iPSC-Derived Neural Organoids.
Costamagna G; Comi GP; Corti S
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800815
[TBL] [Abstract][Full Text] [Related]
20. Induced Pluripotent Stem Cells and Organoids in Advancing Neuropathology Research and Therapies.
Pazzin DB; Previato TTR; Budelon Gonçalves JI; Zanirati G; Xavier FAC; da Costa JC; Marinowic DR
Cells; 2024 Apr; 13(9):. PubMed ID: 38727281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
